| 摘要 |
<p>This invention relates to compounds having the structural formula (I) or pharmaceutically acceptable salts or solvates thereof, wherein R, R2 and R3 are as defined in the specification, pharmaceutical compositions thereof, and methods of treating stroke or central nervous system diseases by administering the compound of the present invention to a patient in need of such treatment.</p> |
